immunotherapy trial updates in nsclc from esmo 2020
Published 4 years ago • 1.9K plays • Length 5:27Download video MP4
Download video MP3
Similar videos
-
4:17
nsclc trial updates at esmo 2022: adaura, destiny-lung02, kn189, kn407 & poseidon
-
2:27
lung art trial updates from esmo 2020
-
5:08
stimuli trial update at esmo 2020
-
7:00
expert report on neoadjuvant immune checkpoint inhibitors for nsclc
-
10:09
esmo 2020 expert video report on long term ici outcomes in lung cancer
-
16:51
post esmo update on impower clinical trial in early stage nsclc
-
4:32
key nsclc updates
-
4:01
the role of immunotherapy in gastrointestinal cancers: an update from esmo
-
3:32
etop/ifct 4-12 stimuli updates from esmo 2020
-
2:05
improving responses to immunotherapy in nsclc
-
2:12
esmo 2020 highlights on adjuvant osimertinib for egfr mutated nsclc: the adaura study
-
3:04
keynote-024 update: pembrolizumab vs platinum-based chemotherapy in nsclc
-
3:55
chrysalis trial update in nsclc
-
7:53
esmo 2020: new developments in the treatment of lung cancer
-
1:54
highlights in lung cancer at esmo 2022
-
4:18
impower110: atezolizumab vs chemo in pd-l1–selected nsclc
-
5:26
updates in 1l urothelial cancer from esmo 2020
-
2:39
esmo 2020 highlights on 1st line lorlatinib for alk nsclc: the crown study
-
35:16
highlights from esmo 2020